期刊文献+

Fatty acid metabolism and cancer development 被引量:5

Fatty acid metabolism and cancer development
原文传递
导出
摘要 Although the type and etiology of cancers are different, pathways in glucose metabolism, pentose phos- phate pathway (PPP) and glutamine metabolism have been reprogrammed in cancer cells to adapt to their rapid growth and proliferation. Recent research has also shown that mul- tiple lipid metabolic pathways are altered in cancer cells. Here, we provide a brief review for the role of fatty acid metabolism in cancer development with a special focus on fatty acid uptake and de novo synthesis, triglycerides syn- thesis, storage and degradation. Reprogramming in fatty acid metabolism plays important roles in providing energy, macromolecules for membrane synthesis and lipid signals during cancer development. Understanding the mechanism of deregulated lipid metabolic pathways in cancer cells would reveal novel therapeutic approaches to combat cancer. 尽管癌症的类型和病原学是不同的,在葡萄糖新陈代谢,戊糖磷酸盐小径(PPP ) 和夫酸安新陈代谢的小径是在癌症细胞的 reprogrammed 适应他们的快速的生长和增长。最近的研究也显示出那多重类脂化合物新陈代谢的小径在癌症房间被改变。这里,我们在癌症开发为丰满的酸新陈代谢的角色向简短评论提供丰满的酸的一个特殊焦点举起和 de novo 合成, triglycerides 合成,存储和降级。在丰满的酸新陈代谢的 Reprogramming 在在癌症开发期间提供精力,为膜合成的大分子和类脂化合物信号起重要作用。理解在癌症房间的新陈代谢的小径将揭示的 deregulated 类脂化合物的机制与癌症作斗争的新奇治疗学的途径。
出处 《Science Bulletin》 SCIE EI CAS CSCD 2016年第19期1473-1479,共7页 科学通报(英文版)
基金 Acknowledgments We thank members of the P.L. Laboratory at Tsinghua University for helpful discussion. This work was supported by the National Basic Research Program (2013CB530602), and the National Natural Science Foundation of China (31430040, 31321003).
关键词 Lipid metabolism TAG Fatty acidsCancer development 脂肪酸代谢 抗癌症 代谢途径 癌细胞 快速生长 谷氨酰胺 从头合成 葡萄糖
  • 相关文献

参考文献75

  • 1Warburg O (1956) On the origin of cancer cells. Science 123:309-314.
  • 2Metallo CM, Gameiro PA, Bell EL et al (2012) Reductive glu- tamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481:380-384.
  • 3Furuhashi M, Hotamisligil GS (2008) Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7:489-503.
  • 4Hotamisligil GS, Bernlohr DA (2015) Metabolic functions of FABPs-mechanisms and therapeutic implications. Nat Rev Endocrinol 11:592-605.
  • 5Horton JD, Goldstein JL, Brown MS (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125-1131.
  • 6Farese RV Jr, Walther TC (2009) Lipid droplets finally get a little R-E-S-P-E-C-T. Cell 139:855-860.
  • 7Walther TC, Farese RV Jr (2012) Lipid droplets and cellular lipid metabolism. Annu Rev Biochem 81:687-714.
  • 8Ye J, DeBose-Boyd RA (2011) Regulation of cholesterol and fatty acid synthesis. Cold Spring Harb Perspect Biol 3:a004754.
  • 9Worgall TS (2008) Regulation of lipid metabolism by sphin- golipids. Subcell Biochem 49:371-385.
  • 10Currie E, Schulze A, Zechner R et al (2013) Cellular fatty acid metabolism and cancer. Cell Metab 18:153-161.

同被引文献20

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部